T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$1.15B |
| 2 |
Apple
AAPL
|
+$742M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$647M |
| 4 |
Flowserve
FLS
|
+$577M |
| 5 |
Visa
V
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NWSA
NEWS CORPORATION CL-A
NWSA
|
+$909M |
| 2 |
Union Pacific
UNP
|
+$741M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$580M |
| 4 |
Edwards Lifesciences
EW
|
+$531M |
| 5 |
Accenture
ACN
|
+$474M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.93% |
| 2 | Consumer Discretionary | 13.87% |
| 3 | Financials | 13.55% |
| 4 | Industrials | 11.67% |
| 5 | Technology | 10.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Kennametal
KMT
$2.43B
| $1.17M | ﹤0.01% |
25,700
+1,900
| +8% | +$82.5K |
|
|
UFS
1627
DELISTED
DOMTAR CORPORATION (New)
UFS
| $1.17M | ﹤0.01% |
29,382
-800
| -3% | -$28.4K |
|
|
ITC
1628
DELISTED
ITC HOLDINGS CORP
ITC
| $1.16M | ﹤0.01% |
37,200
-300
| -0.8% | -$9.11K |
|
1629
Aecom
ACM
$7.65B
| $1.15M | ﹤0.01% |
36,700
| – | – |
|
1630
Old Republic International
ORI
$9.18B
| $1.13M | ﹤0.01% |
73,440
| – | – |
|
|
WCC
1631
WESCO International
WCC
$17.8B
| $1.13M | ﹤0.01% |
14,751
+1,100
| +8% | +$81.6K |
|
|
XLS
1632
DELISTED
EXELIS INC COM STK
XLS
| $1.13M | ﹤0.01% |
76,898
| – | – |
|
|
ALR
1633
DELISTED
Alere Inc
ALR
| $1.12M | ﹤0.01% |
36,740
-1,300
| -3% | -$39.6K |
|
|
CPWR
1634
DELISTED
COMPUWARE CORP
CPWR
| $1.12M | ﹤0.01% |
104,100
| – | – |
|
|
OA
1635
DELISTED
Orbital ATK, Inc.
OA
| $1.11M | ﹤0.01% |
11,425
-1,000
| -8% | -$94.9K |
|
1636
Huntsman Corp
HUN
$1.51B
| $1.11M | ﹤0.01% |
53,700
| – | – |
|
1637
Hyatt Hotels
H
$15.2B
| $1.1M | ﹤0.01% |
25,600
-63,300
| -71% | -$2.78M |
|
1638
SAP
SAP
$242B
| $1.09M | ﹤0.01% |
14,800
| – | – |
|
1639
Hain Celestial
HAIN
$44.6M
| $1.08M | ﹤0.01% |
28,000
| – | – |
|
|
OMED
1640
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $1.07M | ﹤0.01% |
+69,900
| New | +$1.3M |
|
|
URS
1641
DELISTED
URS CORP
URS
| $1.06M | ﹤0.01% |
19,800
| – | – |
|
|
ANAC
1642
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $1.06M | ﹤0.01% |
100,000
-62,187
| -38% | -$544K |
|
|
PPLI
1643
People Inc
PPLI
$2.95B
| $1.06M | ﹤0.01% |
108,551
-21,609
| -17% | -$197K |
|
1644
Dolby
DLB
$5.45B
| $1.06M | ﹤0.01% |
30,640
-28,900
| -49% | -$960K |
|
1645
Atmos Energy
ATO
$26.5B
| $1.05M | ﹤0.01% |
24,660
+1,300
| +6% | +$54.9K |
|
1646
Cullen/Frost Bankers
CFR
$9.72B
| $1.04M | ﹤0.01% |
14,750
-2,900
| -16% | -$206K |
|
1647
Amkor Technology
AMKR
$13.2B
| $1.04M | ﹤0.01% |
242,320
| – | – |
|
|
TWO
1648
DELISTED
Two Harbors Investment
TWO
| $1.03M | ﹤0.01% |
13,325
+1,450
| +12% | +$114K |
|
1649
NNN REIT
NNN
$7.95B
| $1.03M | ﹤0.01% |
32,230
+4,400
| +16% | +$147K |
|
1650
Regal Rexnord
RRX
$10.4B
| $1.03M | ﹤0.01% |
15,100
-1,300
| -8% | -$86.4K |
|
Similar funds
T. Rowe Price Associates's Q3 2013 Portfolio in Review
As of Q3 2013, T. Rowe Price Associates held 2,531 positions worth $400B, up 7% from $374B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q3 2013 filing shows 100 new, 822 increased, 1,027 reduced and 76 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B. The largest sale was NEWS CORPORATION CL-A, an estimated $909M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B.
- T. Rowe Price Associates added most to Apple in Q3 2013, an estimated $742M increase.
- T. Rowe Price Associates's biggest Q3 2013 reduction was Union Pacific, cutting an estimated $741M.
- T. Rowe Price Associates fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $909M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $400B portfolio in Q3 2013.
- T. Rowe Price Associates opened 100 new positions and closed 76 in Q3 2013.
- T. Rowe Price Associates's portfolio value rose 7% quarter-over-quarter to $400B.
Based on T. Rowe Price Associates's 13F filing for Q3 2013, filed 14 Nov 2013.